ImmuCell settles Norbrook dispute, to receive $2M payment

IMMUCELL CORP /DE/

ImmuCell and Norbrook entered a Settlement Deed on May 8, 2026 resolving all claims from a 2019 Development and Supply Agreement.
Norbrook will pay ImmuCell $2,000,000 under the settlement.
The underlying agreement expired on March 31, 2026.
Settlement deed governed by Northern Ireland law; no admission of liability or wrongdoing.
Confidentiality undertakings included in the agreement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IMMUCELL CORP /DE/ entered into Settlement Deed with Norbrook Laboratories Limited valued at $2,000,000 (effective 2026-05-08).

Action: entry
Agreement: settlement
Counterparty: Norbrook Laboratories Limited
Value: $2,000,000
Effective: 2026-05-08

Exact text from the filing

On May 8, 2026, ImmuCell Corporation and Norbrook Laboratories Limited (incorporated and registered in Northern Ireland) entered into a Settlement Deed to resolve and release any and all claims arising out of or relating to an underlying 2019 Development Services and Commercial Supply Agreement between the two companies.

View on SEC.gov

Browse all material agreements →

IMMUCELL CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-26-015945

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.